Skip to content

Psychedelic-assisted therapy: all studies

Page 244 of 294: studies 2,431 to 2,440 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico

Frontiers in Pharmacology June 27, 2022 Snehal Bhatt, Maya Armstrong, Tassy Parker et al. 4 citations

Post-traumatic stress disorder (PTSD), a common condition with potentially devastating individual, family, and societal consequences, is highly associated with substance use disorders (SUDs). The association between PTSD and SUD is complex and may involve adverse childhood experiences (ACEs), historical and multi-generational traumas, and social determinants of health as well as cultural and...

DOI: 10.3389/fphar.2022.905753 (opens in new tab) Psychosocial Indigenous Psychological intervention Population +4

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

Addiction Neuroscience June 22, 2022 Fúlvio Rieli Mendes, Cristiane Dos Santos Costa, Victor Distefano Wiltenburg et al. 55 citations

Substance use disorder (SUD) is a global public health concern that affects millions of people worldwide. Considering current research, addiction has been noted as the last stage of a chronic disease that may impair brain reward circuit responses and affects personal and social life. Treatments for SUD face challenges including availability and limited pharmacological response, often resulting...

β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice

Journal of Psychopharmacology June 20, 2022 Luiz Antonio Miranda de Souza Duarte Filho, Isabela Araújo E Amariz, Rodolfo Hideki Vicente Nishimura et al. 12 citations

Background: Depression is a psychiatric disorder with limited therapy options. Psychedelics are new antidepressant candidates, being the ayahuasca one of the most promising ones. A synergistic combination of N,N-dimethyltryptamine (DMT) and β-carbolines allows ayahuasca antidepressant properties. Another psychedelic and DMT-containing beverage is the jurema wine used religiously by indigenous...

DOI: 10.1177/02698811221104050 (opens in new tab) Antidepressant Traditional medicine Pharmacology Receptor

Applying Lessons From Cannabis to the Psychedelic Highway

JAMA Health Forum June 17, 2022 Kevin F. Boehnke, Alan K. Davis, Jenna McAfee 20 citations

In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers.Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of...

Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions

Journal of Psychedelic Studies June 9, 2022 Annie M. Mccartney, Hugh McGovern, Alexander de Foe 8 citations

Abstract Psychedelic substances such as psilocybin and ketamine may represent the future of antidepressant treatment, due to their rapid and prolonged effects on mood and cognition. The current body of psychedelic research has focused on administration and treatment within a psychiatric context. Here, instead, we put to the test the contention that it is necessary to evaluate the current state...

Mystical experiences without mysticism: An argument for mystical fictionalism in psychedelics

Journal of Psychedelic Studies June 8, 2022 Bradley Armour Garb, Mitchell Earleywine 10 citations

Abstract Mystical experiences frequently precede decreases in human suffering or increased functioning. Therapies that include the ingestion of psychoactive substances in supportive environments often lead to improvements that correlate with the magnitude of the mystical experiences generated. A close look at these phenomena from a philosophy of science perspective might put empiricists in a...

DOI: 10.1556/2054.2022.00207 (opens in new tab) Full text (opens in new tab) Mysticism Epistemology Empiricism Argument complex analysis +2

Don’t be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review

Neuroscience & Biobehavioral Reviews June 6, 2022 Corinna L. Felsch, Kim P. C. Kuypers 23 citations

BACKGROUND: Current first-line treatment for social anxiety disorder (SAD), one of the most prevalent anxiety disorders, is limited in its efficacy. Hence, novel treatment approaches are urgently needed. The current review suggests a combination of meditation-based interventions and the administration of a psychedelic as a future alternative treatment approach. While both separate treatments...

Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice.

Neuropsychopharmacology June 1, 2022 Błażej D. Pędzich, Sarah Rubens, Mehdi Sekssaoui et al.

Psychedelic-assisted psychotherapy gained considerable interest as a novel treatment strategy for fear-related mental disorders but the underlying mechanism remains poorly understood. The serotonin 2A (5-HT2A) receptor is a key target underlying the effects of psychedelics on emotional arousal but its role in fear processing remains controversial. Using the psychedelic 5-HT2A/5-HT2C receptor...

MDMA-Assisted Therapy for Treatment-Resistant Posttraumatic Stress Disorder (PTSD) – One step further toward a patient-centered treatment pathway

European Psychiatry June 1, 2022 S. Pratas Penedos, M.j. Freire, I. Fonseca et al.

IntroductionPTSD is a chronic, debilitating condition with limited treatment efficacy. Accessing traumatic memories often leads to overwhelming distress, impacting treatment process. Current approved pharmacological treatments have exhibited small to moderate effects when compared with placebo. Evidence suggests 3,4,-methylene-dioxymethamphetamine(MDMA)-assisted psychotherapy as a viable option...

Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow.

Psychopharmacology June 1, 2022 Isabel Wießner, Marcelo Falchi, Fernanda Palhano-Fontes et al. 22 citations

Stream of thought describes the nature of the mind when it is freely roaming, a mental state that is continuous and highly dynamic as in mind-wandering or free association. Classic serotonergic psychedelics are known to profoundly impact perception, cognition and language, yet their influence on the stream of thought remains largely unexplored. To elucidate the effects of LSD on the stream of...

DOI: 10.1007/s00213-021-06006-3 (opens in new tab) Full text (opens in new tab) LSD Abstract thinking Forward flow Free association +4